Literature DB >> 3822221

[Tiropramide chlorhydrate in premedication for endoscopic retrograde cholangiopancreatography and its effects on the motor activity of Oddi's sphincter].

A Bolognese, A Lamazza, A Tocchi, C Bruni, M R Crimi, B Fontana, E De Masi.   

Abstract

The activity of tiropramide chlorhydrate in the pre-medication for the endoscopical examinations has been evaluated. In particular ERCP has been studied considering as parameters the timing of the different stages of the examination and the activity of Oddi's sphincter. At the end of endoscopy the pressure of the sphincterial region was measured a 3-way miniature catheter. Patients included in the study were divided into two different groups: group A treated with tiropramide chlorhydrate and diazepam vs group B treated only with diazepam. The group with patients pre-medicated with tiropramide chlorhydrate presented a significant reduction in the timing of the different stages of endoscopy. Endoscopy was better tolerated. Manometry showed an antispastic action of the drug without side effects. An important reduction of the degree and duration of the sphincterial phase activity, with a possible improvement of biliary defluxion into the duodenum, was observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3822221

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  1 in total

1.  Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium.

Authors:  Kang Nyeong Lee; Oh Young Lee; Myung-Gyu Choi; Chong Il Sohn; Kyu Chan Huh; Kyung Sik Park; Joong Goo Kwon; Nayoung Kim; Poong-Lyul Rhee; Seung-Jae Myung; Joon Seong Lee; Kwang Jae Lee; Hyojin Park; Yong Chan Lee; Suck Chei Choi; Hye-Kyung Jung; Sam Ryong Jee; Chang Hwan Choi; Gwang Ha Kim; Moo In Park; In Kyung Sung
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.